JACK H. DEAN - 15 Jun 2023 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Director
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: Jack H. Dean
Issuer symbol
ACXP
Transactions as of
15 Jun 2023
Transactions value $
$0
Form type
4
Filing time
16 Jun 2023, 17:45:50 UTC
Previous filing
06 Jul 2021
Next filing
18 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Stock Option Award $0 +10,000 $0 10,000 15 Jun 2023 Common Stock 10,000 $2.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 15, 2024.